美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ultra納斯達克生物科

112.93

+3.943.62%

成交量：2,376

成交額：26.89萬

市值：9,486.29萬

市盈率：- -

高：113.95

開：113.00

低：112.93

收：108.99

52周最高：126.40

52周最低：55.34

股本：84.00萬

流通股本：84.00萬

量比：0.48

換手率：0.28%

股息：0.33

股息率：0.29%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

安進提交新數據，對美國食品藥品監督管理局（FDA）關於撤回Tavneos的提議提出異議

吉利德科學(GILD)腫瘤組合療法獲歐洲藥品管理局旗下CHMP推薦

CHMP推薦吉利德Trodelvy®聯合Keytruda®用於PD-(L)1陽性一線轉移性三陰性乳腺癌

百濟神州/安進 FIC 雙抗，皮下製劑進入 III 期

數據簡報-邦迪布吉奧埃博拉病毒：正在研發哪些疫苗和治療方法

吉利德與默克聯合研發的每周服用一次的艾滋病口服藥在晚期臨床試驗中成功抑制了病毒

安進就股東提起的指控其隱瞞107億美元税單的訴訟達成和解

Leerink Partners下調吉利德科學評級至「與大盤持平」，目標價大幅調降至127美元

Leerink下調吉利德科學目標價至127美元

Kalshi將允許對臨床試驗和FDA決定進行投注

剛果啓動吉利德實驗性抗病毒藥物邦迪布吉奧埃博拉病毒試驗

Vertex(VRTX)百億美元收購罕見病藥企拓寬內分泌管線佈局

福泰製藥百億美元併購透露了什麼訊號？

吉利德科學(GILD)股票7月10日盤中下跌3.26%：關鍵驅動因素揭曉

TradingKey中文

BUZZ——美國股市動態-SK海力士、達美航空、Circle Internet

滙豐表示，生物製藥領域的併購交易有望創下年度新高

福泰製藥(VRTX)股票7月8日盤中下跌3.09%：投資者必看的核心信息

TradingKey中文

大摩解讀福泰製藥百億收購Crinetics：補齊內分泌管線佈局兩大核心藥物打開增長空間

RBC Capital上調福泰製藥目標價至570美元

吉利德科學(GILD)股票7月7日收盤上漲5.35%：原因全解讀

TradingKey中文

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/BIB/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"Ultra納斯達克生物科","latestPrice":112.932,"timestamp":1789665926649,"preClose":108.9876,"halted":0,"volume":2376,"delay":0,"changeRate":0.03619127313565949,"floatShares":840000,"shares":840000,"eps":0,"marketStatus":"交易中","change":3.9444,"latestTime":"09-17 13:27:27 EDT","open":113,"high":113.95,"low":112.932,"amount":268936.2324,"amplitude":0.009341,"askPrice":112.84,"askSize":20,"bidPrice":112.56,"bidSize":100,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":108.9876,"sharesOutstanding":1040000,"nav":108.5525,"aum":91184100,"dividendRate":0.002896,"bidAskSpread":0.002695,"preHourTrading":{"tag":"盘前","latestPrice":107.01,"preClose":108.9876,"latestTime":"08:07 EDT","volume":8,"amount":856.08,"timestamp":1789646849130,"change":-1.9776,"changeRate":-0.018145,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":108.37,"preClose":108.9876,"latestTime":"19:44 EDT","volume":29,"amount":3116.2656,"timestamp":1789602249698,"change":-0.6176,"changeRate":-0.005667,"amplitude":0},"volumeRatio":0.484693,"impliedVol":0.3753,"impliedVolPercentile":0.0637},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","floatShares":840000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.484693,"shares":840000,"dividePrice":0.327,"high":113.95,"amplitude":0.009341,"preClose":108.9876,"low":112.932,"week52Low":55.34,"pbRate":"--","week52High":126.399,"institutionHeld":0,"latestPrice":112.932,"committee":0.666667,"eps":0,"divideRate":0.002896,"volume":2376,"delay":0,"ttmEps":0,"open":113,"prevYearClose":79.7794,"prevWeekClose":109.7741,"prevMonthClose":116.5968,"prevQuarterClose":100.74,"fiveDayClose":109.5953,"twentyDayClose":126.2177,"sixtyDayClose":89.7431},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIB\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"BIB","amount":0.00714,"announcedDate":"2026-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-25","defaultRemindTime":1774445400000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-25","currency":"USD","dateTimestamp":1774411200000,"payDate":"2026-03-31"},{"date":"2025-12-24","symbol":"BIB","amount":0.134637,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-31"},{"date":"2025-09-24","symbol":"BIB","amount":0.180541,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"BIB","amount":0.170576,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-07-01"},{"date":"2025-03-26","symbol":"BIB","amount":0.130939,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-04-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIB\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-22","recordDate":"2022-12-23","paymentDate":"2022-12-30","value":0.019852,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-28","value":0.038393,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-27","value":0.040324,"currency":"USD"},{"executeDate":"2024-06-26","recordDate":"2024-06-26","paymentDate":"2024-07-03","value":0.26476,"currency":"USD"},{"executeDate":"2024-09-25","recordDate":"2024-09-25","paymentDate":"2024-10-02","value":0.15285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIB\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653080634","title":"安進提交新數據，對美國食品藥品監督管理局（FDA）關於撤回Tavneos的提議提出異議","url":"https://stock-news.laohu8.com/highlight/detail?id=2653080634","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653080634?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 21:44","pubTimestamp":1784900670,"startTime":"0","endTime":"0","summary":"安进提交新数据，对美国食品药品监督管理局关于撤回Tavneos的提议提出异议路透7月24日-安进公司周五表示，该公司已于7月23日向美国食品药品监督管理局提交了新证据，以寻求举行听证会，对该公司的罕见病药物Tavneos拟从美国市场撤回的决定提出异议。美国食品药品监督管理局未立即回应路透的置评请求。美国食品药品监督管理局今年4月表示，除非安进公司主动撤回该药，或FDA局长下令撤回，否则Tavneos将继续在美国市场销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nL4T43Q16X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","PJP","BBH","LU2242652126.USD","BK4534","LU0868494617.USD","LU2089984988.USD","LU1023059063.AUD","LU0320765992.SGD","LU1057294990.SGD","LU1983299246.USD","BK4533","LU0289739699.SGD","BK4566","IBB","SG9999001440.SGD","BK4599","TBXU","LU0109394709.USD","IBBQ","BK4588","LU1571399168.USD","LU2112291526.USD","BK4139","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0058720904.USD","BIB","IE00BJT1NW94.SGD","IE0009355771.USD","LU0889565916.HKD","IE00B2B36J28.USD","LU1061106388.HKD","AMGN","PBE","LU2468319806.SGD","BK4585","LU2242646821.SGD","LU0122379950.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653895100","title":"吉利德科學(GILD)腫瘤組合療法獲歐洲藥品管理局旗下CHMP推薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2653895100","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653895100?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 18:45","pubTimestamp":1784889935,"startTime":"0","endTime":"0","summary":"金吾财讯 | 吉利德科学 宣布，欧洲药品管理局旗下人用药品委员会已发布积极意见，建议批准其Trop-2靶向ADC药物Trodelvy联合帕博利珠单抗，用于既往未接受过全身治疗、且肿瘤PD-L1表达阳性的不可切除局部晚期或转移性三阴性乳腺癌成人患者。若欧盟委员会于2026年晚些时候正式批准该联合疗法，Trodelvy将实现从单药到联合疗法、全面覆盖不同PD-L1表达状态的mTNBC一线治疗布局。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/NmQ4YmNlMWEyMTYyODU5MDQwMjQzMA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NmQ4YmNlMWEyMTYyODU5MDQwMjQzMA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302998","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","IBB","BK4139","LU2468319806.SGD","TBXU","LU0320765992.SGD","MEDI","IE0002270589.USD","LU2089984988.USD","IE00BSNM7G36.USD","LU0823416689.USD","LU1934455194.USD","IE00BZ1G4Q59.USD","LU0965509010.AUD","LU1037948541.HKD","LU1585245621.USD","SG9999015945.SGD","LU0122379950.USD","GILD","BIB","SG9999015978.USD","LU0965509101.SGD","LU0965508806.USD","LU2324357040.USD","CHMP","LU1571399168.USD","BK4588","SG9999015952.SGD","LU1061106388.HKD","LU1934455863.HKD","BK4583","LU2087621335.USD","BMED","BK4550","IBBQ","LU0058720904.USD","LU0234570918.USD","TMED","BK4585","LU0889565916.HKD","LU1023059063.AUD","IE00B19Z3581.USD","IE00B3T34201.USD","LU1066051498.USD","BK4568","SG9999015986.USD","BBH","LU1057294990.SGD","LU0289739699.SGD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185859812","title":"CHMP推薦吉利德Trodelvy®聯合Keytruda®用於PD-(L)1陽性一線轉移性三陰性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1185859812","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185859812?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 18:29","pubTimestamp":1784888958,"startTime":"0","endTime":"0","summary":"欧洲药品管理局人用药品委员会（CHMP）近日给出推荐意见，支持吉利德科学的Trodelvy®与Keytruda®联合使用，用于治疗PD-(L)1阳性的一线转移性三阴性乳腺癌患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455277.USD","BK4585","BK4583","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU1057294990.SGD","IE00B7SZLL34.SGD","LU1674673691.USD","BK4550","BMED","LU0965509101.SGD","MEDI","IBBQ","LU2468319806.SGD","LU1934455194.USD","LU0823416689.USD","SG9999015986.USD","LU0320765992.SGD","IE00B19Z3581.USD","IE0002270589.USD","BK4139","LU0114720955.EUR","SG9999015978.USD","LU0965509283.SGD","SG9999015952.SGD","IE00BZ1G4Q59.USD","LU0965509010.AUD","BK4532","LU1674673428.USD","LU2089984988.USD","LU2112291526.USD","IE00B3T34201.USD","IE00B19Z3B42.SGD","LU1571399168.USD","BK4568","LU1037948897.HKD","LU1066053197.SGD","IBB","BK4566","BBH","LU1061106388.HKD","LU1778281490.HKD","BK4578","LU1023059063.AUD","LU1934455863.HKD","LU1037948541.HKD","LU1066051498.USD","GILD","LU1430594728.SGD","LU1839511570.USD","BIB","LU2087621335.USD","LU0965508806.USD","LU1585245621.USD","BK4588","SG9999015945.SGD","TBXU","LU2324357040.USD","LU0109394709.USD","LU0882574055.USD","LU0122379950.USD","LU0889565916.HKD","LU0289739699.SGD","LU0861579265.USD","TMED","LU0234570918.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653074709","title":"百濟神州/安進 FIC 雙抗，皮下製劑進入 III 期","url":"https://stock-news.laohu8.com/highlight/detail?id=2653074709","media":"新浪医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653074709?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 19:30","pubTimestamp":1784806200,"startTime":"0","endTime":"0","summary":"7 月 22 日，药物临床试验登记与信息公示平台显示，安进和百济神州共同登记了一项在接受含铂一线化疗后的复发性广泛期小细胞肺癌试验参与者中比较 Tarlatamab皮下给药与静脉给药的 III 期研究DeLLphi-315。在皮下剂型的开发方面，安进和百济神州于 2024 年 9 月启动了一项在广泛期小细胞肺癌受试者中评价 Tarlatamab 皮下给药的安全性、耐受性、药代动力学和初步抗肿瘤活性的 Ib 期研究 DeLLphi-308。而本次启动的DeLLphi-315 研究是塔拉妥单抗皮下给药方案启动的首个 III 期临床试验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-07-23/doc-iniivazc5268721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BFTCPJ56.SGD","BK1500","IBB","AMGN","ONC","LU0588546209.SGD","LU0289739699.SGD","BK4588","LU1969619763.USD","KURE","SG9999001440.SGD","LU0307460666.USD","LU1251922891.USD","LU0122379950.USD","IE0002141913.USD","BK4585","BK4139","BBH","BK4599","IE00BJT1NW94.SGD","BIB","688235","BK4534","TBXU","BK1583","LU0058720904.USD","LU0868494617.USD","IBBQ","LU2328871848.SGD","LU2242646821.SGD","PJP","BK4134","PBE","IE00B4R5TH58.HKD","III","LU1061106388.HKD","LU0889565916.HKD","BK1588","LU1303224171.USD","06160","BK4581","IE0009355771.USD","LU1770034418.SGD","LU1983299246.USD","LU1719994722.HKD","LU2242652126.USD","LU2112291526.USD","LU1571399168.USD","LU0320765992.SGD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653618768","title":"數據簡報-邦迪布吉奧埃博拉病毒：正在研發哪些疫苗和治療方法","url":"https://stock-news.laohu8.com/highlight/detail?id=2653618768","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653618768?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 20:52","pubTimestamp":1784724736,"startTime":"0","endTime":"0","summary":"数据简报-邦迪布吉奥埃博拉病毒：正在研发哪些疫苗和治疗方法更新疫情数据，补充临床试验进展及诊断检测详情Mariam Sunny/Jennifer Rigby路透7月22日-全球卫生部门正争分夺秒地寻找医疗方案，以遏制刚果民主共和国东部由邦迪布吉奥  埃博拉病毒株引发的疫情。与更常见的扎伊尔毒株不同，目前尚无针对邦迪布吉奥毒株的获批疫苗或治疗方法。据该公司称，实验室研究表明该药物对邦迪布吉奥埃博拉病毒具有活性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nL4T43O1A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","MRNX","LU1015430645.USD","LU0976567544.SGD","LU2125154935.USD","LU0997586432.USD","LU1116320737.USD","LU2539964713.USD","BK4566","LU0011850046.USD","GILD","LU0920840948.USD","IE00BZ1G4Q59.USD","LU0006306889.USD","LU0965508806.USD","LU0158827948.USD","LU1934455863.HKD","688317","LU1481599808.USD","BK4198","BK4550","LU0047473722.EUR","BMED","LU0957799991.USD","LU0265550359.USD","LU2089283258.USD","GNOM","LU1084165304.USD","LU0390134368.USD","LU1116320901.HKD","LU1323610961.USD","LU1201861249.SGD","LU0868494708.USD","LU0969580561.USD","LU1019632923.USD","LU0889565916.HKD","LU1078025761.USD","LU1829250122.USD","SG9999015952.SGD","LU2087621335.USD","BK4559","LU0128525929.USD","LU1983299246.USD","LU1929549753.HKD","LU0784385840.USD","IE00B3T34201.USD","LU2279689827.SGD","IE00BJJMRZ35.SGD","MEDI","IE0002141913.USD","LU0792757196.USD","LU1064927863.SGD","LU0265550946.USD","LU0889565080.SGD","IDNA","MRNY","LU2360032135.SGD","LU0114720955.EUR","REGN","LU2237443622.USD","BK4007","LU0553294199.USD","LU0965509101.SGD","LU1880407132.USD","LU1066051811.HKD","LU1035773651.USD","LU0203345920.USD","LU2491050071.SGD","LU0757432116.USD","LU2357627491.SGD","LU1934455277.USD","LU2108987350.USD","SGXZ57979304.SGD","LU0052756011.USD","LU0827474353.SGD","LU1989772923.USD","LU0861579265.USD","MRNA","IE00B2B36J28.USD","BK4534","VHT","IE00BSNM7G36.USD","LU1355424745.HKD","PAWZ","SG9999013999.USD","LU0211328371.USD","LU1153584641.USD","IYH","LU0211326839.USD","LU1273509221.SGD","LU2461242641.AUD","LU1941712348.USD","SG9999002224.SGD","SG9999014559.SGD","LU1066051225.USD","LU0557290698.USD","LU1585245621.USD","LU0889566641.SGD","LU1267930490.SGD","LU2293690082.USD","LU0823416689.USD","LU1170363599.USD","LU0738911758.USD","SG9999015358.SGD","FHLC","IE0009355771.USD","LU0965509010.AUD","IBB","LU0965509283.SGD","LU2237443978.SGD","LU2468319806.SGD","LU0942090050.USD","LU0211327993.USD","SG9999014567.USD","FTXH","LU0171293334.USD","LU1778281490.HKD","LU2106854487.HKD","LU2089984988.USD","LU0047473722.SGD","LU0310799852.SGD","LU1863844665.USD","LU0985320562.USD","LU0077335932.USD","SG9999002232.USD","LU1496350502.SGD","LU2125154778.USD","BK4501","LU1267930573.SGD","PPH","LU1051770623.HKD","LU1066053197.SGD","BK0239","IE00B1BXHZ80.USD","LU2023250504.SGD","LU2237443895.HKD","BIB","LU1003076772.USD","BK4548","LU1061106388.HKD","LU3187612489.SGD","LU2133065610.SGD","LU0823434740.USD","LU2361045086.USD","LGHT","LU0310800379.SGD","SG9999015986.USD","LU0708994859.HKD","BK4585","LU0289739699.SGD","LU2362541513.USD","LU1046234339.USD","IE000M9KFDE8.USD","LU2023251221.USD","LU1674673428.USD","LU2112291526.USD","IE0034235188.USD","LU0689626769.HKD","IE00BKPKM643.USD","SG9999015978.USD","LU0784384876.USD","SG9999014542.SGD","LU1261432733.SGD","LU0640478417.SGD","LU0882574055.USD","WDNA","LU0098860793.USD","LU0432979614.USD","LU2293690249.USD","BK4516","LU2091194634.USD","IE00BN8TJ469.HKD","LU2433249047.HKD","LU0980610538.SGD","BK4583","LU0211326755.USD","LU1989771016.USD","HRTS","LU1941712264.USD","LU0997586515.USD","IE00BLSP4452.SGD","LU0868494617.USD","LU0130517989.USD","BK4568","SG9999001440.SGD","LU1196032939.SGD","LU1019634622.SGD","LU0130102774.USD","LU0203347892.USD","LU2023250843.SGD","LU0124676726.USD","LU0823434583.USD","IBBQ","LU2361044949.HKD","SG9999015945.SGD","IE00BKVL7J92.USD","SG9999014575.USD","IE00BFTCPJ56.SGD","LU0949170426.SGD","LU2355687059.USD","LU0857590862.USD","LU2491049909.HKD","IE00B19Z3B42.SGD","XLV","LU1037948897.HKD","SG9999001176.USD","LU0128525689.USD","LU0208291251.USD","IE00B19Z3581.USD","LU0058720904.USD","LU0106261372.USD","LU1267930813.SGD","LU0887340254.USD","MRK","LU1093756325.SGD","LU1023059063.AUD","03165","LU0320765646.SGD","BK4551","LU1917777945.USD","LU0122379950.USD","IE00B4R5TH58.HKD","AZN.UK","IE00BLSP4239.USD","LU0496365809.HKD","LU0499090636.EUR","LU0920783379.SGD","LU2114397693.USD","LU0053666078.USD","LU0784383803.USD","OSUR","BK5011","LU2361044865.SGD","LU0320765489.SGD","LU1003077747.HKD","BK4588","IE00BBT3K403.USD","LU2089284900.SGD","LU1037948541.HKD","LU1093756168.USD","LU0784385170.HKD","LU0234570918.USD","LU1674673691.USD","LU1104425308.USD","LU0823399737.USD","LU2237438978.USD","LU0963555726.SGD","LU1162221912.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","LU0029864427.USD","LU0310800965.SGD","IHE","LU1057294990.SGD","LU2237443465.HKD","RXL","LU2324357040.USD","LU0964806797.USD","LU1863844749.USD","LU1481600234.SGD","LU0575583348.USD","LU0526926950.USD","LU1291159041.SGD","LU1934455194.USD","LU2362540622.SGD","LU1119994496.HKD","TMED","LU1430594728.SGD","LU1496350171.SGD","LU1880407215.USD","LU2125909593.SGD","LU0477156953.USD","TBXU","LU0238689110.USD","LU2237443549.SGD","BK4533","LU0859254822.USD","LU0648001328.SGD","LU1301847155.USD","LU0266013472.USD","LU0345777659.USD","IXJ","BBH","LU1989772840.SGD","LU2125909247.SGD","LU0960981461.USD","SG9999001176.SGD","BK4139","LU0949170772.SGD","LU1153585028.USD","LU2491050154.USD","BK4532","JDOC","LU0211331839.USD","LU1571399168.USD","LU0109394709.USD","GDOC","LU1974910355.USD","LU1814569148.SGD","LU1923622614.USD","IE00B7SZLL34.SGD","LU0661504455.SGD","TRUH","LU0234572021.USD","LU1487256676.USD","IE0002270589.USD","LU0070302665.USD","LU1839511570.USD","LU1699723380.USD","BK4578","SG9999015341.SGD","LU1267930227.SGD","LU2362541273.HKD","LU0171276677.USD","LU0545039389.USD","LU0972486137.USD","LU1069347547.HKD","LU0345777147.USD","LU2237443382.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653204798","title":"吉利德與默克聯合研發的每周服用一次的艾滋病口服藥在晚期臨床試驗中成功抑制了病毒","url":"https://stock-news.laohu8.com/highlight/detail?id=2653204798","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653204798?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 01:23","pubTimestamp":1784654592,"startTime":"0","endTime":"0","summary":"吉利德与默克联合研发的每周服用一次的艾滋病口服药在晚期临床试验中成功抑制了病毒路透7月21日-吉利德科学公司和默克公司周二表示，其正在试验中的每周服用一次的艾滋病毒口服药在两项晚期临床试验中成功抑制了病毒，这为该药的监管申报提供了支持，该疗法有望成为此类疾病治疗中首个此类方案。默克公司的每日一次艾滋病口服复方制剂Idvynso已于4月获得美国食品药品监督管理局批准 ，为艾滋病患者提供了另一种治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL4T43N1N1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU1291159041.SGD","VHT","SG9999001176.USD","FTXH","RXL","IBB","LU0868494708.USD","LU2324357040.USD","LU0266013472.USD","PPH","BBH","LU2023250843.SGD","GDOC","LU1023059063.AUD","MRK","IE00BJJMRZ35.SGD","TMED","IE00B2B36J28.USD","LU1093756168.USD","SG9999014542.SGD","LU1778281490.HKD","MEDI","LU1983299246.USD","PAWZ","HRTS","LU0058720904.USD","LU1923622614.USD","LU2089984988.USD","IHE","FHLC","LU1699723380.USD","GILD","LU0432979614.USD","LU0889565916.HKD","IYH","LU2087621335.USD","JDOC","IXJ","BMED","SG9999015952.SGD","TRUH","LU1989771016.USD","IBBQ","LU1929549753.HKD","TBXU","LU1066053197.SGD","XLV","LU0861579265.USD","LU1941712348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653206285","title":"安進就股東提起的指控其隱瞞107億美元税單的訴訟達成和解","url":"https://stock-news.laohu8.com/highlight/detail?id=2653206285","media":"路透中文","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653206285?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 23:07","pubTimestamp":1784646437,"startTime":"0","endTime":"0","summary":"安进就股东提起的指控其隐瞒107亿美元税单的诉讼达成和解Jonathan Stempel路透纽约7月21日-安进公司就一起指控其延迟披露可能因六年税款申报不足而需向美国国税局补缴107亿美元的诉讼，达成了一项7400万美元的和解协议。安进否认有任何不当行为，并于周二表示仍认为这些指控毫无依据。美国国税局就安进公司所谓的“转让定价”做法，要求其补缴87亿美元税款及利息，并处以20亿美元罚款。安进公司表示，美国税务法院的裁决可能于今年作出。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL4T43N1GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IBB","IE0009355771.USD","LU2089984988.USD","BK4533","PJP","LU1057294990.SGD","LU2242646821.SGD","SG9999001440.SGD","LU0889565916.HKD","IBBQ","AMGN","IE00B2B36J28.USD","LU2468319806.SGD","LU2242652126.USD","IE00BJJMRZ35.SGD","BK4585","LU1983299246.USD","BK4588","LU1571399168.USD","IE0002141913.USD","LU0289739699.SGD","LU0058720904.USD","BK4566","LU1061106388.HKD","LU0122379950.USD","LU0109394709.USD","PBE","LU0868494617.USD","LU2112291526.USD","BK4581","LU1023059063.AUD","LU0320765992.SGD","BK4599","IE00BJT1NW94.SGD","BBH","BIB","BK4139","IE00B4R5TH58.HKD","TBXU","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169878111","title":"Leerink Partners下調吉利德科學評級至「與大盤持平」，目標價大幅調降至127美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169878111","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169878111?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 12:03","pubTimestamp":1784606620,"startTime":"0","endTime":"0","summary":"投资银行Leerink Partners调整了对生物技术公司吉利德科学的股票评级。该机构将其评级从原先的“跑赢大盘”下调至“与大盘持平”，反映出其对该公司近期前景更为审慎的看法。\n与此同时，Leerink Partners也显著下调了吉利德科学的目标股价，从每股146美元大幅削减至127美元。这一调整意味着该机构对该公司未来股价的预期有所降低。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","BMED","LU0320765992.SGD","LU0889565916.HKD","LU1066051498.USD","LU1674673691.USD","MEDI","GILD","LU1057294990.SGD","LU1934455194.USD","LU1674673428.USD","LU1037948541.HKD","LU1839511570.USD","LU1037948897.HKD","SG9999015952.SGD","LU1778281490.HKD","IBBQ","LU1430594728.SGD","BK4578","LU2112291526.USD","TBXU","LU0965509101.SGD","BK4139","IBB","IE0002270589.USD","LU1934455863.HKD","LU2089984988.USD","LU0965508806.USD","BK4566","IE00BZ1G4Q59.USD","SG9999015945.SGD","BBH","LU1571399168.USD","IE00BKVL7J92.USD","LU0109394709.USD","LU0114720955.EUR","LU2468319806.SGD","TMED","BK4550","BK4568","BIB","LU0861579265.USD","SG9999015978.USD","LU0882574055.USD","LU0965509010.AUD","IE00BSNM7G36.USD","BK4583","IE00B7SZLL34.SGD","LU0122379950.USD","BK4532","LU0289739699.SGD","LU0058720904.USD","LU0965509283.SGD","LU1585245621.USD","LU1934455277.USD","LU1061106388.HKD","LU2087621335.USD","SG9999015986.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0234570918.USD","LU1023059063.AUD","LU1066053197.SGD","BK4588","LU0823416689.USD","BK4585","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653210240","title":"Leerink下調吉利德科學目標價至127美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653210240","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653210240?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 10:35","pubTimestamp":1784601350,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["GILD","LU0861579265.USD","LU0965509101.SGD","LU1674673428.USD","LU2324357040.USD","MEDI","IBB","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","LU2089984988.USD","LU1778281490.HKD","LU0320765992.SGD","IBBQ","LU0823416689.USD","LU0882574055.USD","LU1066053197.SGD","LU0289739699.SGD","IE00B19Z3B42.SGD","UDN","UUP","LU0234570918.USD","LU1585245621.USD","BMED","IE00BKVL7J92.USD","LU0058720904.USD","LU1674673691.USD","LU0965509010.AUD","LU0889565916.HKD","LU2087621335.USD","LU0965509283.SGD","BBH","LU0122379950.USD","LU0114720955.EUR","LU2112291526.USD","LU2468319806.SGD","LU1934455863.HKD","SG9999015945.SGD","BK4578","BK4550","BK4139","SG9999015978.USD","BK4585","SG9999015986.USD","LU1839511570.USD","LU1023059063.AUD","BIB","LU0109394709.USD","BK4583","LU1037948541.HKD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652423028","title":"Kalshi將允許對臨床試驗和FDA決定進行投注","url":"https://stock-news.laohu8.com/highlight/detail?id=2652423028","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652423028?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 23:59","pubTimestamp":1784217550,"startTime":"0","endTime":"0","summary":"Kalshi将允许对临床试验和FDA决定进行投注路透7月16日-预测市场平台Kalshi周四表示，将开始接受针对临床试验结果和美国食品药品监督管理局监管审查结果的投注，这标志着药物研发的赔率首次向公众公开。Kalshi表示，这些市场允许投资者针对单一药物而非整个公司进行投注。Kalshi和AppliedXL将在试验完成受试者招募后才发布相关合约。Kalshi平台于2021年上线，允许用户对体育赛事、选举结果和天气等事件进行投注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nL4S43I1IP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","SG9999015945.SGD","LU1934455863.HKD","LU2324357040.USD","LU2089984988.USD","LU2112291526.USD","LU0965509283.SGD","LU1571399168.USD","LU0882574055.USD","BK4532","BK4588","BK4583","IE00B19Z3581.USD","LU1674673691.USD","LU1061106388.HKD","MEDI","LU0109394709.USD","LU2468319806.SGD","LU1839511570.USD","LU1674673428.USD","IBBQ","BK4585","BMED","IE00B19Z3B42.SGD","GILD","LU1066051498.USD","LU0122379950.USD","BBH","LU0058720904.USD","BK4566","LU1585245621.USD","IE0002270589.USD","IE00B7SZLL34.SGD","LU0889565916.HKD","SMMT","SG9999015978.USD","LU0234570918.USD","LU0965508806.USD","LU1057294990.SGD","LU1037948541.HKD","LU1037948897.HKD","LU0114720955.EUR","BK4578","SG9999015952.SGD","IBB","LU0861579265.USD","BIB","LU1934455277.USD","LU0823416689.USD","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105068","title":"剛果啓動吉利德實驗性抗病毒藥物邦迪布吉奧埃博拉病毒試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105068","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105068?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 20:47","pubTimestamp":1784033246,"startTime":"0","endTime":"0","summary":"刚果启动吉利德实验性抗病毒药物邦迪布吉奥埃博拉病毒试验路透7月14日-刚果民主共和国的研究人员周二表示，他们已开始招募受试者，参与一项临床试验，测试吉利德科学公司GILD.O旗下实验性抗病毒药物奥贝德西韦作为刚果和乌干达当前邦迪布吉奥埃博拉疫情的暴露后治疗药物。在临床前研究中，奥贝德西韦已显示出对丝状病毒的活性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nL4S43G1EN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","IE0002270589.USD","LU1061106388.HKD","LU1571399168.USD","LU1023059063.AUD","BK4585","LU1585245621.USD","BBH","LU0965509283.SGD","BMED","LU0289739699.SGD","LU0823416689.USD","LU2468319806.SGD","LU1934455194.USD","SG9999015986.USD","MEDI","LU1037948897.HKD","LU1934455277.USD","LU1430594728.SGD","LU1066053197.SGD","BK4532","LU1778281490.HKD","IBB","LU2087621335.USD","LU0861579265.USD","LU1057294990.SGD","BK4578","BK4550","BIB","LU0234570918.USD","LU0965509010.AUD","LU1674673691.USD","LU0114720955.EUR","LU1839511570.USD","BK4566","LU1934455863.HKD","LU2089984988.USD","IE00BSNM7G36.USD","BK4583","LU0320765992.SGD","LU0965508806.USD","GILD","IE00BZ1G4Q59.USD","IE00B3T34201.USD","IBBQ","BK4588","SG9999015978.USD","IE00B7SZLL34.SGD","LU2324357040.USD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651117599","title":"Vertex(VRTX)百億美元收購罕見病藥企 拓寬內分泌管線佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=2651117599","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651117599?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 22:10","pubTimestamp":1783951848,"startTime":"0","endTime":"0","summary":"金吾财讯 | Vertex Pharmaceuticals  与 Crinetics Pharmaceuticals  共同披露收购协议，企业将以每股 85 美元现金完成标的全额收购，交易对应 Crinetics 整体股权价值约 100 亿美元，扣除标的账面现金后净交易对价 88 亿美元，交易预计 2026 年第三季度完成，消息落地后 Crinetics 盘后股价实现翻倍上涨。Vertex 计划依托自有现金搭配债务工具完成交易资金筹措，美国银行、摩根士丹利提供 45 亿美元全额过渡性融资，收购落地后企业罕见病内分泌赛道产品矩阵将实现大幅扩容。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302497","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ9MQY76.HKD","IE0002270589.USD","IE0009355771.USD","LU1069344957.HKD","BK4585","LU1585245621.USD","BBH","LU0109394709.USD","LU0757428866.USD","LU2362541513.USD","IDNA","IE00B19Z9Z06.USD","BK4532","LU1035775433.USD","LU1778281490.HKD","IBB","LU0432979614.USD","LU2362540622.SGD","LU2462157665.USD","SG9999001176.USD","LU0061475181.USD","IE00B894F039.SGD","PBE","IE00B2B36J28.USD","BK4007","LU0256863811.USD","LU1093756325.SGD","IE00BJT1NW94.SGD","BIB","LU0234570918.USD","LU2237438978.USD","LU1093756168.USD","SG9999013999.USD","LU2362541273.HKD","IE00BFTCPJ56.SGD","LU0079474960.USD","LU2456880835.USD","VRTX","LU2417539215.USD","LU0889565916.HKD","IE00B19Z3581.USD","VERX","LU1674673428.USD","IBBQ","BK4588","CRNX","LU0566484027.USD","IE0002141913.USD","IE00B4R5TH58.HKD","SG9999001176.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650760159","title":"福泰製藥百億美元併購透露了什麼訊號？","url":"https://stock-news.laohu8.com/highlight/detail?id=2650760159","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650760159?lang=zh_tw&edition=fundamental","pubTime":"2026-07-11 22:55","pubTimestamp":1783781749,"startTime":"0","endTime":"0","summary":"01百亿美元级现金并购的底气福泰制药2025年全年营收120.01亿美元，同比增长9%，非GAAP净利润47.5亿美元，毛利率维持85%以上高位，账面现金及有价证券超过123亿美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1783569458583958068","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4567","IE00BFTCPJ56.SGD","IBB","KCE","LU0079474960.USD","LU1069344957.HKD","LU1585245621.USD","LU0234570918.USD","IE00B894F039.SGD","LU1093756325.SGD","LU2236285917.USD","LU0289739699.SGD","BK4588","LU1778281490.HKD","SG9999001176.SGD","LU2417539215.USD","IE0002141913.USD","BK4532","BK4139","BBH","CALF","LU0061475181.USD","IE00B19Z9P08.USD","IDNA","IE00BJT1NW94.SGD","BIB","LU1093756168.USD","LU0823416689.USD","LU0058720904.USD","LU0109394709.USD","IBBQ","MYLD","LU2362540622.SGD","PBE","IE00B4R5TH58.HKD","IE0002270589.USD","IE00B19Z3581.USD","IE00B19Z9Z06.USD","IE00B2B36J28.USD","IE0009355771.USD","LU1035775433.USD","IE00BZ9MQY76.HKD","IE00BJJMRZ35.SGD","SGXZ57979304.SGD","VRTX","XMMO","LU2462157665.USD","LU2324357040.USD","LU0320765992.SGD","SG9999001176.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650131357","title":"吉利德科學(GILD)股票7月10日盤中下跌3.26%：關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2650131357","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650131357?lang=zh_tw&edition=fundamental","pubTime":"2026-07-11 00:16","pubTimestamp":1783700165,"startTime":"0","endTime":"0","summary":"• 吉利德科学股价在一项实体瘤三期临床试验失败后下跌。\n• 强劲的就业数据推高了美债收益率，令今日生物科技板块估值承压。\n• 由于肿瘤产品组合销售时间表推迟，分析师可能会下调其盈利预测。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262023383-market-movers-gild-20260710","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","LU0965509010.AUD","LU1934455277.USD","BK4568","LU1934455863.HKD","IE00BZ1G4Q59.USD","BK4566","LU0889565916.HKD","LU1057294990.SGD","BK4550","LU0965509283.SGD","LU1061106388.HKD","LU1066053197.SGD","IE00B19Z3B42.SGD","IE00B3T34201.USD","BK4583","LU2324357040.USD","LU0289739699.SGD","LU0882574055.USD","LU0965509101.SGD","BK4585","LU0058720904.USD","LU2112291526.USD","LU1674673428.USD","LU2087621335.USD","BIB","LU1066051498.USD","GILD","LU1037948541.HKD","LU1674673691.USD","IBB","LU1430594728.SGD","LU2468319806.SGD","BK4578","SG9999015952.SGD","BK4588","LU0823416689.USD","BBH","LU0861579265.USD","LU1934455194.USD","IE00B7SZLL34.SGD","MEDI","BK4139","IBBQ","LU1571399168.USD","IE00B19Z3581.USD","LU0122379950.USD","SG9999015986.USD","LU0965508806.USD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650118208","title":"BUZZ——美國股市動態-SK海力士、達美航空、Circle Internet","url":"https://stock-news.laohu8.com/highlight/detail?id=2650118208","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650118208?lang=zh_tw&edition=fundamental","pubTime":"2026-07-10 19:37","pubTimestamp":1783683425,"startTime":"0","endTime":"0","summary":".N** 费米公司FRMI.O：热点 - 因发行3.75亿美元可转换债券股价暴跌nL6N43C0K8** 吉利德科学公司GILD.O:** 礼来公司LLY.N:** 艾伯维公司ABBV.N:** 百健公司BIIB.O:热点 - 汇丰银行称生物制药并购交易有望创下年度新高nL4N43C0P3** 达美航空公司DAL.N:热点 - 因预测第三季度利润将超出预期，股价上涨nL4N43C0QQ** Circle Internet Group IncCRCL.N:热点 - 获最终监管批准在美国设立信托银行后股价上涨nL4N43C0SJ** SK海力士公司SKHY.O:热点 - 筹集265亿美元后，即将迎来备受期待的美国上市nL4N43C0TG","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nL4S43C0TU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0795875169.SGD","LU2168564149.EUR","LU2023250504.SGD","IBB","IE00BKPKM429.USD","LU0965509101.SGD","LU2129689514.USD","LU2168564495.EUR","SG9999011175.SGD","THNR","LU1430594728.SGD","IE00BJLML261.HKD","IE000F7OJYX1.SGD","LU0289739699.SGD","BK4599","LU0912757837.SGD","LU1934455194.USD","CURE","SG9999001440.SGD","IE00BZ1G4Q59.USD","SG9999015952.SGD","IE000BZT7R73.USD","LU2456880835.USD","LU0385154629.USD","BK4516","LU0203347892.USD","LU2756315664.SGD","LU0787776722.HKD","IE00B1XK9C88.USD","LU1066053197.SGD","FHLC","ELIL","LU1023059063.AUD","LU2552382058.USD","LU1267930227.SGD","BK4566","LU0345770308.USD","LU1791807156.HKD","LU0006306889.USD","PJP","BIIB","IE00BJJMRX11.SGD","LU1861217088.USD","LU0823434740.USD","SG9999014880.SGD","LU2552382215.SGD","LU1127390331.HKD","LU0820561909.HKD","MEDI","LU0266013472.USD","LU0238689110.USD","LU0353189680.USD","BK4550","LU0882574139.USD","BK4559","CANC","IE00B42XCP33.USD","LU0109391861.USD","LU0057025933.USD","BK4500","LU1291159041.SGD","LU0058720904.USD","LU0133085943.USD","LU2237438978.USD","SG9999003800.SGD","IE00BLSP4452.SGD","LU0868494617.USD","LLYZ","LU0471298694.HKD","LU2491050071.SGD","LU1868837136.USD","LU2264538146.SGD","LLY","FTXH","LU0689472784.USD","JDOC","LU0354030438.USD","LU1629891620.HKD","LU0061475181.USD","LU1069344957.HKD","LU2106854487.HKD","LU2133065610.SGD","LU0170899867.USD","SKHYV","LU0114720955.EUR","LU0820562030.AUD","LU2063271972.USD","LU1934455277.USD","LU0289961442.SGD","LU0738911758.USD","LU1074936037.SGD","LU0861579265.USD","LU2087625088.SGD","SG9999015986.USD","IE00B894F039.SGD","BK4008","LU0210536198.USD","SG9999013999.USD","SGXZ51526630.SGD","ABBV","IE000WAW04H5.SGD","LU0310800379.SGD","BIB","IE00BN29S564.USD","SGXZ31699556.SGD","LU2471134796.USD","LU0672654240.SGD","LU0310800965.SGD","LU0106831901.USD","LU1839511570.USD","IE00B4R5TH58.HKD","LU1037948897.HKD","LU2491049909.HKD","LU0859254822.USD","BK4585","IBLC","LU0256863811.USD","IE00BVYPNW00.USD","LU0823434583.USD","LU0122379950.USD","LU2462157665.USD","LU2750360641.GBP","LU2324357040.USD","LU0354030511.USD","LU2236285917.USD","LU1267930490.SGD","BKCH","LU2213496289.HKD","SG9999001176.SGD","LU2129689431.USD","BK4533","LU1778281490.HKD","BK4583","IE00BGHQF631.EUR","CRCA","GILD","LU0052756011.USD","AGNG","FRMI","IE00B1BXHZ80.USD","IE00BKDWB100.SGD","IXJ","SGXZ57979304.SGD","HRTS","LU1989772923.USD","LU1093756325.SGD","IE00B7KXQ091.USD","LU1712237335.SGD","VHT","LU2023251221.USD","LU2089984988.USD","LU2168563687.JPY","LU1037948541.HKD","LLYX","IHE","LU0094547139.USD","LU0198837287.USD","LU1670628061.USD","CCUP","IE0002141913.USD","LU1974910355.USD","SG9999014898.SGD","IE00B3PB1722.GBP","LU1323610961.USD","BK4139","LU0320765059.SGD","WDNA","LU1670627923.USD","BBH","BK4578","LU2129689605.HKD","LU1244550221.USD","LU1674673691.USD","LU0472753341.HKD","LU1720051108.HKD","LU0353189763.USD","LU1929549753.HKD","LU2237443465.HKD","LU0795875086.SGD","XLV","LU1804176565.USD","LU0553294199.USD","LU0466842654.USD","LU2468319806.SGD","LU1145028129.USD","LU1093756168.USD","IE0009355771.USD","LU1983299246.USD","BK4023","LU2237443622.USD","LU0965509283.SGD","IE00B19Z9P08.USD","LU2361045086.USD","LU1066051498.USD","GDOC","BK4222","LU1861558580.USD","LU2108987350.USD","SG9999001176.USD","LU1917777945.USD","LU2471134879.HKD","LU0471298777.SGD","LU1267930730.SGD","LU1934455863.HKD","LU0964807845.USD","SG9999015978.USD","LU1861559042.SGD","LU0124676726.USD","PBE","LU0158827948.USD","OZEM","LU1720051017.SGD","LU1267930573.SGD","LU2461242641.AUD","LLII","SKHY","LU0158827781.USD","SG9999018865.SGD","LU1162221912.USD","LU0345770993.USD","LU2552382132.HKD","LU0106261372.USD","BK4532","LU1718418525.SGD","IE00BJT1NW94.SGD","LU0545039389.USD","IE00B19Z3581.USD","IE00BFSS7M15.SGD","MEDX","IE00B19Z3B42.SGD","LU1003077747.HKD","LU0320765646.SGD","BMED","LU1571399168.USD","LU2211815571.USD","SG9999017495.SGD","LU1551013342.USD","SGXZ81514606.USD","LU0109394709.USD","LU0128525929.USD","LU1868836757.USD","IE0004445015.USD","LU1244550494.USD","IE00B7SZLL34.SGD","JETS","IE00B775H168.HKD","LU2237443549.SGD","LU0882574055.USD","LU1668664300.SGD","LU0823416689.USD","LU2168564222.USD","LU2271345857.HKD","IE000SO60NU8.SGD","SG9999015945.SGD","LU1585245621.USD","LU2357627491.SGD","BK4588","IE0005OL40V9.USD","PPH","LU0289739343.SGD","IE00BJJMRY28.SGD","BK4581","LU0128525689.USD","LU0203345920.USD","LU2750360997.AUD","LU2112291526.USD","IE00B4JS1V06.HKD","LU0942090050.USD","IE00BK4W5M84.HKD","LU1989771016.USD","LU0310799852.SGD","DAL","LU0211327993.USD","IE0002270589.USD","LU1035775433.USD","LU0965508806.USD","LU2347655156.SGD","LU0708995401.HKD","LU2756315318.SGD","ILDR","LU0889565916.HKD","BK4534","LU2028103732.USD","IE00BFMHRM44.USD","LU0203201768.USD","LU2087621335.USD","IE000MB6IJN5.SGD","IE00BLSP4239.USD","LU0211328371.USD","LU2360107671.USD","LU1366192091.USD","LU0456855351.SGD","LU0234570918.USD","LU0689626769.HKD","LU1548497426.USD","LU1868837300.USD","LU0943347566.SGD","BK4007","LU0432979614.USD","LU0029864427.USD","SG9999014906.USD","IE00BN8TJ469.HKD","LU0234572021.USD","LU0661504455.SGD","IE00BBT3K403.USD","LU0079474960.USD","CRCD","IYH","LU1496350502.SGD","LU0965509010.AUD","LU2357305700.SGD","LU2089283258.USD","SGXZ99366536.SGD","ELIS","LU0320765992.SGD","LU0640476718.USD","LU1232071149.USD","LU1280957306.USD","IE00B3T34201.USD","LU1064131342.USD","IE00B2B36J28.USD","LU0256863902.USD","LU1732800096.USD","LU0098860793.USD","IE0004445239.USD","LU1057294990.SGD","LU0203202063.USD","LU2417539215.USD","LU2746668974.SGD","IE00B19Z9Z06.USD","LU1244550577.SGD","LU1674673428.USD","IE00BJJMRZ35.SGD","LU1989772840.SGD","LU0316494557.USD","CRCG","LU0820561818.USD","LU2471134523.USD","LU2746668461.USD","LU1868836591.USD","LU0069063385.USD","LU1861220207.SGD","GB00BDT5M118.USD","LU0511384066.AUD","LU0683600562.USD","LU0949170772.SGD","LU1551013425.SGD","LU2168564065.EUR","LU2360106947.USD","LU2237443895.HKD","LU1814569148.SGD","BK4568","LU0708994859.HKD","LU1868836914.USD","LU1061106388.HKD","RXL","SG9999014914.USD","CRCL","IE00BVYPNV92.GBP","LU2089284900.SGD","IE0000B7K699.USD","LU0097036916.USD","LU1988902786.USD","IE00BFTCPJ56.SGD","LU0985320562.USD","SG9999018857.SGD","IE00BK4W5L77.USD","LU0096364046.USD","IE00BKVL7J92.USD","LU0225283273.USD","ICRC","IBBQ","CRCO","IE0001KFT4U8.USD","LU2361044949.HKD","LU2237443978.SGD","IE00BDGV0183.EUR","LU2265009873.SGD","IE00BFSS8Q28.SGD","LU0323591593.USD","LU1732799900.SGD","LU2471134952.CNY","LU0417517546.SGD","LU2023250330.USD","LU0786609619.USD","LU2111349929.HKD","LU0868494708.USD","LU2896262040.SGD","IE00BSNM7G36.USD","LU1623119135.USD","IE00BWXC8680.SGD","LU2602419157.SGD","LU2361044865.SGD","LU2237443382.USD","LU2491050154.USD","LU1496350171.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650718438","title":"滙豐表示，生物製藥領域的併購交易有望創下年度新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2650718438","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650718438?lang=zh_tw&edition=fundamental","pubTime":"2026-07-10 18:33","pubTimestamp":1783679616,"startTime":"0","endTime":"0","summary":"BUZZ-汇丰表示，生物制药领域的并购交易有望创下年度新高7月10日-** 汇丰表示，生物制药领域的并购活动“正朝着创纪录的一年迈进”** 该券商指出，随着核心药品面临专利压力，大型制药企业正通过并购 (link) 来强化产品管线，并缓解对未来增长的担忧** 报告指出，截至4月，吉利德科学公司（GILD.O）在三笔收购中支付了约110亿美元的预付款；截至5月，礼来公司（LLY.N）的收购支出超过1","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nL4T43C0Q7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2646069778.SGD","NUVL","XLV","IBB","LLII","LU0795875086.SGD","LLYX","BIIB","PPH","BK5011","MEDI","LU1267930730.SGD","IYH","LU0786609619.USD","MEDX","ABBV","VHT","LU1804176565.USD","GILD","JDOC","WDNA","BIB","RXL","CANC","LU0683600562.USD","PBE","ILDR","LU1323610961.USD","LU1934455277.USD","ELIL","CURE","THNR","LLY","OZEM","ELIS","BMED","IBBQ","HRTS","FHLC","IHE","GSK.UK","LLYZ","LU0820561909.HKD","PJP","FTXH","AGNG","BBH","LU1267930573.SGD","GDOC","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650913850","title":"福泰製藥(VRTX)股票7月8日盤中下跌3.09%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2650913850","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650913850?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 02:15","pubTimestamp":1783534535,"startTime":"0","endTime":"0","summary":"• Vertex Pharmaceuticals已同意以100亿美元现金收购Crinetics Pharmaceuticals。\n• 此次收购溢价超过Crinetics股价的100%。\n• 在估值创历史新高期间，高管们根据预先安排的交易计划出售了公司股票。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262018348-market-movers-vrtx-20260708","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","LU2324357040.USD","IE00BZ9MQY76.HKD","LU1585245621.USD","IE00B19Z3581.USD","BIB","LU2462157665.USD","IBB","LU2417539215.USD","LU2362541273.HKD","BK4532","IE00B19Z9P08.USD","IE00B894F039.SGD","SG9999001176.USD","LU1093756168.USD","LU0058720904.USD","BK4585","LU1778281490.HKD","IE0002270589.USD","LU0234570918.USD","LU1069344957.HKD","IDNA","PBE","LU0079474960.USD","IE00BJJMRZ35.SGD","LU1674673691.USD","LU2362540622.SGD","LU0289739699.SGD","LU1035775433.USD","BBH","IE00BJT1NW94.SGD","BK4139","LU0432979614.USD","IE00B2B36J28.USD","LU2362541513.USD","SGXZ57979304.SGD","LU0889565916.HKD","IE00B19Z9Z06.USD","IBBQ","SG9999001176.SGD","SG9999013999.USD","IE0002141913.USD","LU0417517546.SGD","LU2237438978.USD","VRTX","LU1674673428.USD","LU1430594728.SGD","IE00B4R5TH58.HKD","LU1093756325.SGD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649299398","title":"大摩解讀福泰製藥百億收購Crinetics：補齊內分泌管線佈局 兩大核心藥物打開增長空間","url":"https://stock-news.laohu8.com/highlight/detail?id=2649299398","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649299398?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 20:01","pubTimestamp":1783512080,"startTime":"0","endTime":"0","summary":"摩根士丹利发布研报，对福泰制药以100亿美元收购Crinetics的交易进行解读。此次收购将为福泰制药新增第五大业务支柱——内分泌药物，补齐公司管线布局。根据公告，每股85美元的收购价格较Crinetics周一的收盘价溢价了102%。值得注意的是，摩根士丹利担任福泰制药的财务顾问，协助该公司达成收购Crinetics的协议。","market":"us","thumbnail":"https://community-static.tradeup.com/news/7870ada20f73cf52a4a0efa576cd369c","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/7870ada20f73cf52a4a0efa576cd369c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464871.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"大摩解读福泰制药(VRTX.US)百亿收购Crinetics：补齐内分泌管线布局 两大核心药物打开增长空间","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1363072403.SGD","LU2133065610.SGD","BK4139","IE00BZ9MQY76.HKD","LU1720051108.HKD","IDNA","LU2111349929.HKD","LU2362541273.HKD","LU0882574139.USD","IE00B19Z3581.USD","IE0009355771.USD","BK4588","BBH","LU0267386448.USD","LU2456880835.USD","LU0098860793.USD","LU0390134368.USD","LU2089284900.SGD","LU2362540622.SGD","LU2236285917.USD","IE0002141913.USD","LU1674673691.USD","LU1791710400.SGD","PBE","LU0823416689.USD","BK4581","BK4533","IAI","LU0109394709.USD","VRTX","LU0432979614.USD","LU1244550221.USD","IE00B19Z9P08.USD","IE0002270589.USD","LU1585245621.USD","LU0210528500.USD","LU2487616109.SGD","IBBQ","KBWB","BIB","LU2237438978.USD","LU0058720904.USD","IE00B894F039.SGD","LU0053666078.USD","SG9999001176.USD","IBB","LU0528227936.USD","LU1732799900.SGD","LU0079474960.USD","LU1720051017.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649969921","title":"RBC Capital上調福泰製藥目標價至570美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649969921","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649969921?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 16:24","pubTimestamp":1783499090,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0823416689.USD","LU2417539215.USD","RY","BBH","LU0234570918.USD","IBB","BK4585","LU2362540622.SGD","LU2456880835.USD","LU1778281490.HKD","VRTX","LU0029864427.USD","LU1093756325.SGD","LU0417517546.SGD","LU0128525929.USD","LU0310800379.SGD","BK4139","BK4207","LU1093756168.USD","SG9999001176.USD","SG9999013999.USD","UDN","GSIB","IE00B4R5TH58.HKD","LU1267930573.SGD","LU1069344957.HKD","LU0708994859.HKD","BK4533","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","LU2237438978.USD","PBE","LU0289739699.SGD","IBBQ","IE00B19Z9Z06.USD","IE00BJJMRZ35.SGD","UUP","LU0058720904.USD","IE00B2B36J28.USD","IDNA","IE0009355771.USD","IE00B894F039.SGD","LU2462157665.USD","LU0320765992.SGD","BK4567","IE00B19Z9P08.USD","LU2324357040.USD","BIB","IE00B19Z3B42.SGD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649930146","title":"吉利德科學(GILD)股票7月7日收盤上漲5.35%：原因全解讀","url":"https://stock-news.laohu8.com/highlight/detail?id=2649930146","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649930146?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 04:15","pubTimestamp":1783455335,"startTime":"0","endTime":"0","summary":"• 吉利德（Gilead）股价在三期艾滋病毒（HIV）临床试验取得成功结果后上涨。\n• 欧洲监管机构批准将Trodelvy用于一线癌症单药治疗。\n• 汇丰银行（HSBC）将吉利德股票评级上调至买入，理由是其管线估值被低估。","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262017041-market-movers-gild-20260707","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455277.USD","BK4583","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU1057294990.SGD","BK4550","BMED","LU0965509101.SGD","MEDI","IBBQ","LU2468319806.SGD","LU1934455194.USD","SG9999015986.USD","IE00B19Z3581.USD","IE0002270589.USD","BK4139","SG9999015978.USD","LU0965509283.SGD","SG9999015952.SGD","IE00BZ1G4Q59.USD","LU0965509010.AUD","BK4532","LU2089984988.USD","LU2112291526.USD","IE00B3T34201.USD","IE00B19Z3B42.SGD","BK4568","LU1066053197.SGD","IBB","BK4566","BBH","LU1778281490.HKD","BK4578","LU1023059063.AUD","LU1037948541.HKD","GILD","LU1430594728.SGD","BIB","LU2087621335.USD","LU0965508806.USD","LU1585245621.USD","BK4588","SG9999015945.SGD","LU2324357040.USD","LU0109394709.USD","LU0122379950.USD","LU0889565916.HKD","LU0289739699.SGD","LU0234570918.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":7,"totalSize":153,"code":"91000000","status":"200"}]}}